Menu
Recruiting NCT04405115

Improving Survivorship Care for Older Adults After Chemotherapy

No phase Interventional Survivorship

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Geriatric Assessment.
Who it may be relevant to
Registry conditions: Survivorship. Basic parameters: from 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The researchers want to find out if older adults receiving a survivorship care plan followed by a geriatric assessment visit improves quality of life and satisfaction with care compared to receiving only a survivorship care plan for older adults who have completed chemotherapy for cancer treatment.

Detailed description

This study is a pilot randomized trial to examine whether a geriatric assessment-enhanced survivorship care plan improves satisfaction, knowledge and health-related quality of life compared to standard survivorship care plans among older adults who have completed curative chemotherapy for cancer. The investigator's hypothesis is that older adults who receive a geriatric assessment-enhanced survivorship care plan will report improved satisfaction with care, health-related quality of life, and knowledge and preparedness for survivorship care needs.

Interventions

  • Behavioral Geriatric Assessment
    Geriatric Assessment Visit

Primary outcome measures

  • Study retention rate [Time frame: 4-6 months]
  • Number of months needed for completion of trial enrollment [Time frame: 4-6 months]
  • Acceptability of the study: survey [Time frame: 4-6 months]
Secondary outcome measures (4)
  • Patient satisfaction assessment by PSCC (Patient Satisfaction with Cancer related Care) tool [Time frame: 4-6 months]
  • Health related quality of life assessment by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire EORTC QLQ-30 [Time frame: 4-6 months]
  • Health related quality of life assessment by QLQ14 [Time frame: 4-6 months]
  • Self rated patient knowledge and preparedness measured by PLANS assessment tool (Preparing for Life as a New Survivor) [Time frame: 4-6 months]

Eligibility criteria

Inclusion criteria

  • age 65 years and above and
  • Have diagnosis of cancer and have completed chemotherapy with curative (not palliative) intent and
  • have been scheduled to receive a survivorship care plan from an oncology navigator.

Exclusion criteria

  • advanced dementia or serious cognitive impairment that would impede ability to participate in the interview
  • nursing home resident.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Supportive care

Study locations

United States · 1 center
  • Community Cancer Institute — Clovis

Identifiers

NCT: NCT04405115 · 2019028

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗